Italy Immunosuppressant Drugs Market Size & Outlook
Related Markets
Italy immunosuppressant drugs market highlights
- The Italy immunosuppressant drugs market generated a revenue of USD 2,309.9 million in 2020 and is expected to reach USD 3,520.7 million by 2027.
- The Italy market is expected to grow at a CAGR of 6.2% from 2021 to 2027.
- In terms of segment, monoclonal antibodies was the largest revenue generating drug class in 2020.
- Monoclonal Antibodies is the most lucrative drug class segment registering the fastest growth during the forecast period.
Immunosuppressant drugs market data book summary
| Market revenue in 2020 | USD 2,309.9 million |
| Market revenue in 2027 | USD 3,520.7 million |
| Growth rate | 6.2% (CAGR from 2020 to 2027) |
| Largest segment | Monoclonal antibodies |
| Fastest growing segment | Monoclonal Antibodies |
| Historical data | 2016 - 2019 |
| Base year | 2020 |
| Forecast period | 2021 - 2027 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Calcineurin Inhibitors, MTOR Inhibitors, Antiproliferative Agents, Monoclonal Antibodies |
Other key industry trends
- In terms of revenue, Italy accounted for 2.4% of the global immunosuppressant drugs market in 2020.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2027.
- In Europe, Germany immunosuppressant drugs market is projected to lead the regional market in terms of revenue in 2027.
- UK is the fastest growing regional market in Europe and is projected to reach USD 10,167.1 million by 2027.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Immunosuppressant Drugs Market Scope
Immunosuppressant Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| No records found. | ||||
Italy immunosuppressant drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to immunosuppressant drugs market will help companies and investors design strategic landscapes.
Monoclonal antibodies was the largest segment with a revenue share of 73.52% in 2020. Horizon Databook has segmented the Italy immunosuppressant drugs market based on calcineurin inhibitors, mtor inhibitors, antiproliferative agents, monoclonal antibodies covering the revenue growth of each sub-segment from 2016 to 2027.
According to OECD data, Italy has the highest number of geriatric population after Japan. In the year 2019, 23.1% of the total population in Italy was estimated to be aged 65 years and above. These demographic trends impose numerous implications for the government and private sectors in the country.
According to NCBI, cavitated caries lesions, severe periodontitis were prevalent among 42.10% of the Italian population. In 2017, approximately 7.9% of the population suffered from periodontal disease in Italy. These factors are likely to propel the sealant and adhesive market growth in the country. The trend of cosmetic dentistry procedures is being rapidly adopted by Italian population, mainly due to their growing attention to their appearance.
Italians are sensitive to oral hygiene and considers it as an essential part of the overall care. However in Italy oral healthcare is mainly provided under private arrangements. The public healthcare system provides only 5–8% of oral healthcare services and this percentage varies from region to region.
Reasons to subscribe to Italy immunosuppressant drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Italy immunosuppressant drugs market databook
-
Our clientele includes a mix of immunosuppressant drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy immunosuppressant drugs market, including forecasts for subscribers. This country databook contains high-level insights into Italy immunosuppressant drugs market from 2016 to 2027, including revenue numbers, major trends, and company profiles.
Partial client list
Italy immunosuppressant drugs market size, by drug class, 2016-2027 (US$M)
Italy Immunosuppressant Drugs Market Share, 2020 & 2027 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
